ArticleOPEN ACCESS

Metformin: Treating the cause of Fanconi anemia?

Blood
DOI: 10.1182/blood-2016-11-748129
6Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Zhang et al have uncovered that metformin, a first-line treatment for type 2 diabetes, can improve hematopoietic stem cell (HSC) function and reduce cancer risk in a mouse model of Fanconi anemia (FA).1

Cite

CITATION STYLE

APA

Crossan, G. P. (2016, December 15). Metformin: Treating the cause of Fanconi anemia? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-11-748129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free